Adult High Risk Vaccine Initiative

Adult High Risk Vaccine Initiative (AHB)

The purpose of the Adult High Risk Vaccine Initiative (AHB) is to improve the delivery of viral hepatitis prevention services in health-care settings and public health programs that serve adults at risk for viral hepatitis. The primary goals are:

Increase

the number of doses of hepatitis B-containing vaccine purchased by immunization program grantees;

Reduce

the incidence of acute hepatitis B among adults in the United States; and

Improve

overall vaccination coverage among adults.

Vaccines are free, but there may be an administration fee charged to give the vaccines. The maximum fee is $20.72 per dose.

Available vaccines include:

  • Adacel (Tdap)
  • Havrix (Hepatitis A)
  • Heplisav-B (Hepatitis B)
  • Gardasil (HPV)
  • Prevnar20 (PCV)
  • Shingrix (Zoster)
  • Comirnaty (COVID-19)
  • Spikevax (COVID-19)
  • Novavax (COVID-19)

For more information, visit the following links:


Adult Immunization

Adults Immunization Recommendations

Adult High Risk Vaccine Initiative (AHB)

Behavorial Risk Factor Surveillance System

Adult Immunization Resources

AHB vaccines under this Initiative are available only to people who meet the following conditions:

  1. Individuals who are 19 years of age and older; and
  2. who have no insurance.

a. COVID-19 vaccines may be available for under-insured individuals who seek vaccination at select Federally Qualified Health Centers (FQHC)/Rural Health Centers (RHC) locations or their Local Health Department.

Participating healthcare providers by Health District

*Only supplies COVID-19 vaccines